Saha A et al. |
Synthesis and biological evaluation of a targeted DNA-binding transcriptional activator with HDAC8 inhibitory activity. |
2013 |
Bioorg. Med. Chem. |
pmid:23719282
|
Schäfer S et al. |
Phenylalanine-containing hydroxamic acids as selective inhibitors of class IIb histone deacetylases (HDACs). |
2008 |
Bioorg. Med. Chem. |
pmid:18054239
|
Whitehead L et al. |
Human HDAC isoform selectivity achieved via exploitation of the acetate release channel with structurally unique small molecule inhibitors. |
2011 |
Bioorg. Med. Chem. |
pmid:21723733
|
Feng T et al. |
Novel N-hydroxyfurylacrylamide-based histone deacetylase (HDAC) inhibitors with branched CAP group (Part 2). |
2013 |
Bioorg. Med. Chem. |
pmid:23820574
|
Mukherjee P et al. |
Structural insights into the Plasmodium falciparum histone deacetylase 1 (PfHDAC-1): A novel target for the development of antimalarial therapy. |
2008 |
Bioorg. Med. Chem. |
pmid:18362073
|
Di Micco S et al. |
Structural basis for the design and synthesis of selective HDAC inhibitors. |
2013 |
Bioorg. Med. Chem. |
pmid:23693069
|
Shivashimpi GM et al. |
Molecular design of histone deacetylase inhibitors by aromatic ring shifting in chlamydocin framework. |
2007 |
Bioorg. Med. Chem. |
pmid:17881232
|
Giannini G et al. |
N-Hydroxy-(4-oxime)-cinnamide: a versatile scaffold for the synthesis of novel histone deacetylase [correction of deacetilase] (HDAC) inhibitors. |
2009 |
Bioorg. Med. Chem. Lett. |
pmid:19285395
|
Lee S et al. |
Design, synthesis, and evaluation of isoindolinone-hydroxamic acid derivatives as histone deacetylase (HDAC) inhibitors. |
2007 |
Bioorg. Med. Chem. Lett. |
pmid:17588744
|
Nishino N et al. |
Synthesis and histone deacetylase inhibitory activity of cyclic tetrapeptides containing a retrohydroxamate as zinc ligand. |
2004 |
Bioorg. Med. Chem. Lett. |
pmid:15109626
|
Wang DF et al. |
QSAR studies of PC-3 cell line inhibition activity of TSA and SAHA-like hydroxamic acids. |
2004 |
Bioorg. Med. Chem. Lett. |
pmid:14741273
|
Desai D et al. |
SelSA, selenium analogs of SAHA as potent histone deacetylase inhibitors. |
2010 |
Bioorg. Med. Chem. Lett. |
pmid:20167479
|
Jose B et al. |
Novel histone deacetylase inhibitors: cyclic tetrapeptide with trifluoromethyl and pentafluoroethyl ketones. |
2004 |
Bioorg. Med. Chem. Lett. |
pmid:15454224
|
Pabba C et al. |
Design and synthesis of aryl ether and sulfone hydroxamic acids as potent histone deacetylase (HDAC) inhibitors. |
2011 |
Bioorg. Med. Chem. Lett. |
pmid:21109435
|
Gupta PK et al. |
Inhibitors selective for HDAC6 in enzymes and cells. |
2010 |
Bioorg. Med. Chem. Lett. |
pmid:20947351
|
Shinji C et al. |
Design and synthesis of phthalimide-type histone deacetylase inhibitors. |
2005 |
Bioorg. Med. Chem. Lett. |
pmid:16137884
|
Vasudevan A et al. |
Heterocyclic ketones as inhibitors of histone deacetylase. |
2003 |
Bioorg. Med. Chem. Lett. |
pmid:14592473
|
Choi E et al. |
Structure and property based design, synthesis and biological evaluation of γ-lactam based HDAC inhibitors. |
2011 |
Bioorg. Med. Chem. Lett. |
pmid:21256006
|
Charrier C et al. |
Antiproliferative activities of a library of hybrids between indanones and HDAC inhibitor SAHA and MS-275 analogues. |
2007 |
Bioorg. Med. Chem. Lett. |
pmid:17897824
|
Van Ommeslaeghe K et al. |
Amide analogues of TSA: synthesis, binding mode analysis and HDAC inhibition. |
2003 |
Bioorg. Med. Chem. Lett. |
pmid:12749885
|